Jamie Dananberg
2019
In 2019, Jamie Dananberg earned a total compensation of $1.6M as Chief Medical Officer at Unity Biotechnology, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,005 |
|---|---|
| Option Awards | $780,473 |
| Salary | $428,500 |
| Stock Awards | $189,675 |
| Other | $11,200 |
| Total | $1,591,853 |
Dananberg received $780.5K in option awards, accounting for 49% of the total pay in 2019.
Dananberg also received $182K in non-equity incentive plan, $428.5K in salary, $189.7K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Jamie Dananberg's compensation ranked 7,039th out of 13,971 executives tracked by ExecPay. In other words, Dananberg earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,039 out of 13,971 | 50th |
Division Manufacturing | 2,698 out of 5,695 | 53rd |
Major group Chemicals And Allied Products | 992 out of 2,194 | 55th |
Industry group Drugs | 841 out of 1,880 | 55th |
Industry Pharmaceutical Preparations | 619 out of 1,392 | 56th |
Source: SEC filing on April 30, 2021.
Dananberg's colleagues
We found three more compensation records of executives who worked with Jamie Dananberg at Unity Biotechnology in 2019.